For instance, while mutation analysis of BRAF, RET, and RAS genes, which are part of the MAPK pathway, is already integrated into clinical practice for diagnostic and prognostic purposes in thyroid cancer [20], there is limited understanding of how genes within this pathway contribute to tumorigenesis in these tumors. Here, BRAF is linked to thyroid cancer.